SG11201900960WA - Composition for ameliorating peripheral nerve disorder caused by anticancer agent - Google Patents

Composition for ameliorating peripheral nerve disorder caused by anticancer agent

Info

Publication number
SG11201900960WA
SG11201900960WA SG11201900960WA SG11201900960WA SG11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA
Authority
SG
Singapore
Prior art keywords
anticancer agent
peripheral nerve
disorder caused
nerve disorder
composition
Prior art date
Application number
SG11201900960WA
Other languages
English (en)
Inventor
Kentaro Nakamura
Hidekazu Tonouchi
Hideo Nakajima
Mami MURAMATSU
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of SG11201900960WA publication Critical patent/SG11201900960WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
SG11201900960WA 2016-08-19 2017-08-18 Composition for ameliorating peripheral nerve disorder caused by anticancer agent SG11201900960WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016161457A JP6325036B2 (ja) 2016-08-19 2016-08-19 抗がん剤に起因する末梢神経障害を改善するための組成物
PCT/JP2017/029647 WO2018034345A1 (ja) 2016-08-19 2017-08-18 抗がん剤に起因する末梢神経障害を改善するための組成物

Publications (1)

Publication Number Publication Date
SG11201900960WA true SG11201900960WA (en) 2019-03-28

Family

ID=61196731

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900960WA SG11201900960WA (en) 2016-08-19 2017-08-18 Composition for ameliorating peripheral nerve disorder caused by anticancer agent

Country Status (5)

Country Link
JP (1) JP6325036B2 (zh)
CN (1) CN109641027A (zh)
SG (1) SG11201900960WA (zh)
TW (1) TWI754662B (zh)
WO (1) WO2018034345A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI802808B (zh) * 2019-07-24 2023-05-21 生展生物科技股份有限公司 嗜熱鏈球菌菌株st4用於製備改善化療藥物引起之腹瀉、食慾不振及幫助體重維持之輔助組合物之用途
WO2023053828A1 (ja) * 2021-09-30 2023-04-06 テルモ株式会社 化学療法制御装置、化学療法制御システム、化学療法制御装置の制御方法及び化学療法制御プログラム
JP7323688B1 (ja) 2022-08-25 2023-08-08 盈太企業股▲ふん▼有限公司 折り畳み式収納装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
ES2385069T3 (es) * 2007-08-31 2012-07-17 Kyushu University, National University Corporation Agentes profilácticos o de alivio para trastorno nervioso periférico inducido por agente anti-cáncer
JP5946642B2 (ja) * 2009-11-30 2016-07-06 株式会社明治 小腸に良い栄養組成物
CN103561756A (zh) * 2011-05-27 2014-02-05 株式会社明治 用于预防以及/或者改善癌症引起的非可逆性的代谢紊乱的组合物
SG11201402693VA (en) * 2011-11-30 2014-09-26 Meiji Co Ltd Nutritional composition for improving intestinal flora
RU2595857C2 (ru) * 2012-05-31 2016-08-27 Кинки Юниверсити Средство для профилактического и/или терапевтического лечения периферической нейропатической боли, вызываемой противораковым средством
WO2015013932A1 (en) * 2013-07-31 2015-02-05 Meiji Co., Ltd. Nutritional composition for inhibiting growth of tumor
WO2015163316A1 (ja) * 2014-04-22 2015-10-29 味の素株式会社 末梢神経障害の予防又は改善用組成物
TWI726846B (zh) * 2014-06-25 2021-05-11 日商明治股份有限公司 飢餓素分泌促進劑

Also Published As

Publication number Publication date
JP2018027925A (ja) 2018-02-22
JP6325036B2 (ja) 2018-05-16
CN109641027A (zh) 2019-04-16
TW201817442A (zh) 2018-05-16
TWI754662B (zh) 2022-02-11
WO2018034345A1 (ja) 2018-02-22

Similar Documents

Publication Publication Date Title
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
SG11201900960WA (en) Composition for ameliorating peripheral nerve disorder caused by anticancer agent
PH12019550084A1 (en) Oligosaccharides for flavour generation
EA201691171A1 (ru) Композиция, применимая для активации женской репродуктивной способности
MX2017016320A (es) Composiciones nutricionales y metodos para promover el desarrollo cognitivo.
MX2016012694A (es) Composiciones nutritivas dirigidas a sujetos que tienen alergias a proteinas de la leche de vaca.
BR112018003474A2 (pt) bactérias lactobacillus fermentum que reduzem a concentração de acetaldeído
MY183250A (en) Pediatric nutritional composition with milk peptides for healthy growth and development
ZA201908610B (en) Il-15 protein complex pharmaceutical composition and uses thereof
CO2019011847A2 (es) Albúminas de guisante mejoradas, método para obtener las mismas y aplicaciones de las mismas
TW201613631A (en) Ghrelin secretion promoter
MX2021004467A (es) Productos lacteos filtrados acidos reducidos en carbohidratos.
BR112018000682A2 (pt) processo para a preparação de um produto de leite fermentado
MY184761A (en) Transesterified oil and plastic oil/fat composition using same as hardstock
PH12018502207A1 (en) Methods of manufacturing nutritional formulations
PH12018500166A1 (en) Synthetic nutrional compostions tailored for infants of specific ages, and nutritional systems comprising them
MX2016007635A (es) Serie de formulas infantiles adaptadas a la edad con contenido de lactosa y contenido de proteinas optimos.
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12018500165A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2019007315A (es) Metodos para producir biomasa rica en dha, acido palmitico y proteinas con un microorganismo eucariota.
PH12016501390A1 (en) Nutritional compositions containing ceramide
MX2016016313A (es) Sumplemento alimenticio a base de ferulato de etilo.
MX2021010210A (es) Una composicion nutricional para usar para mejorar la funcion ejecutiva.
Яковлева Ekaterina Yakovleva